Cubit Diagnostics
PrivateLast Round
SAFE
May 7, 2026
Total Funding Raised
$2.6M
Momentum Score
25 /100
Company Overview
Cubit Diagnostics is a diagnostics company developing an integrated immunoassay and molecular benchtop analyzer designed to simplify clinical workflows and expand access to high-quality diagnostics at the point of care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cubit Diagnostics Comps
Public and private peers based on sector, stage, and business model.
Cubit Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | May 7, 2026 | ||||
| Grant | Dec 2, 2024 | ||||
| Seed | Dec 22, 2021 |
Cubit Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Completed a SAFE round of funding.
- Feb 2, 2026
Monthly visitors grew 338% MoM, reaching 2.3K.
Cubit Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cubit Diagnostics's valuation, stock price, and market status.
